Chief Executive Officer
Ananda is Chief Executive Officer at MPE. She joined the team in March 2013.
She started getting involved in patient advocacy in 2007. Since then she has collaborated with a number of patient organisations across Europe. She has worked at the leading Institute of Public Law (IDP Barcelona) and the European Commission (DG Health and Consumers). Currently she is also Vice-chair of the Workgroup of European Cancer Patient Advocacy Networks (WECAN) and a member of the Ethics Committee at the Chamber of Physicians of Bavaria, Germany.
Ananda speaks Spanish, German, English, Catalan and French. She is currently based in Munich, Germany.
Ana joined the MPE team as Communications Manager in September 2016.
Ana worked as a journalist on weekly newspapers specialising in health and on consumer health monthly magazines. She has been involved in different patient advocacy groups, first as a volunteer and later on within the communication department. Since 2014, Ana worked as PR and press consultant in the health department of an international PR agency developing communication strategies for the main pharmaceutical companies.
Ana has been involved in producing two books focused on patients with cancer as a co-writer and editorial co-ordinator. She speaks Spanish and English.
Kate is Head of Policy and Access at MPE. She joined the team in September 2017.
Kate previously worked for eight years in the Policy Team at Myeloma UK, where she was involved in influencing a range of policy and reimbursement decisions affecting myeloma patient access to good quality care and effective new drugs. She was involved in a number of patient and public advisory panels in the UK healthcare system, including for the Scottish Medicines Consortium, the drug approval body in Scotland.
She been involved in a wide-range of patient organisation networks, both nationally and internationally – most recently chairing the Blood Cancers Alliance, an information-sharing network of haematological cancer charities in the UK.
Kate currently lives and works in Edinburgh, Scotland.
Ingrid joined the MPE team as Finance and Reporting Officer in August 2018.
Ingrid has broad experience in large, medium-sized and start-up companies. She worked as referent and assistant to Executive Boards. In this role she was responsible, for board-, management- and finance-reporting and controlling. She has proficient expertise in project and programme management and implementation of administrative processes as well as in marketing and public relations.
In the health area she worked for the Innovative Medicines Initiative (IMI) project EUPATI. The European Patients’ Academy. This is a pan-European project implemented as a public-private partnership by a collaborative multi-stakeholder consortium from the pharmaceutical industry, academia, not-for-profit, and patient organisations. As Finance and Reporting Officer she supported the EUPATI Director in preparing reports for IMI and the international consortium members. Financial monitoring, control and analysis were part of her responsibility. Ingrid is based in Munich, Germany.
Julia Tolley joined the team as Operations Manager in February 2020.
Tamika joined the team as Scientific Engagement Manager in April 2020.
Tamika is originally from Connecticut, United States and she is currently based in Munich, Germany.
Katie joined MPE in April 2020 as Patient Advocacy Programme Manager.
Anne-Pierre joined in April 2020 to manage the Access to medicines Secretariat.
Anne-Pierre holds a MSc in Economic Evaluation for Health Technology Assessment from the University of York, a MSc in European Social Policy from the London School of Economics and a Diploma in Political Sciences from the Institut d’Etudes Politiques of Strasbourg. She worked as general delegate and program manager in cancer prevention through nutrition and lifestyle (World Cancer Research Fund & Institut National du Cancer [INCa]) and market access director (Kantar Health, Lundbeck & Sanofi).
Jayne joined MPE in October 2020 as Head of Patient Evidence.
She previously worked as the Health Services Research Manager at Myeloma UK, as a lecturer in in Psychology at the University of Stirling, and on clinical trials at the University of Glasgow (Neurology) and University College London (Institute of Child Health). She is an honorary research fellow at the University of Stirling. She has published work in the fields of patient preferences, the economic and societal impacts of disease, perceptions of patient reported outcome measures (PROMs), and patient and carer perceptions of clinical neurology trials in stroke.
Jayne has worked closely with patients as part of her previous clinical roles within the NHS and children’s hospices. She has also represented patients on research boards and worked with patient and carer panels on large projects and grants, including the Scottish Government funded Cancer Medicines Outcomes Programme (CMOP) and National Institute of Health Research (NIHR) funded studies.
She lives and works in Edinburgh, Scotland.
Lili joined MPE as Project Officer in November 2020.
Lili has experience as a laboratory-based researcher focusing on novel drug design at pharmaceutical companies and in academia. Since moving to Hannover, Germany in 2019, she has worked as a freelance scientific writer, collaborating with the European Patients’ Academy on Therapeutic Innovation (EUPATI) among other organisations. Lili speaks English, Hungarian, conversational German and Japanese.
Aisuluu joined MPE as Project Coordinator in November 2020.